These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7810838)

  • 1. [Apoptosis in HIV infection].
    Maroto Vela Mdel C
    An R Acad Nac Med (Madr); 1994; 111(2):289-311; discussion 311-6. PubMed ID: 7810838
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunopathogenesis of human immunodeficiency virus.
    Ahsan N; Langhoff E
    Semin Nephrol; 1998 Jul; 18(4):422-35. PubMed ID: 9692354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome.
    Neubert J; Laws HJ; Adams O; Münk C; Krämer M; Niehues T; Korn K; Fleckenstein B; Petri E; Borkhardt A
    AIDS; 2010 Jan; 24(2):327-8. PubMed ID: 20029271
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporary seronegativity in a human immunodeficiency virus type 1-infected man.
    Zaaijer HL; Bloemer MH; Lelie PN
    J Med Virol; 1997 Jan; 51(1):80-2. PubMed ID: 8986953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to the herpes simplex virus type 2 glycoprotein G in sera of human immunodeficiency virus-infected patients in Slovakia.
    Bystrická M; Soláriková L; Gasparíková L; Staneková D; Mokrás M; Kovácová E; Sabó A; Russ G
    Acta Virol; 1998 Nov; 42(5):319-24. PubMed ID: 10358733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals.
    Banda NK; Simon GR; Sipple JD; Terrell KL; Archer P; Shpall EJ; Akkina RK; Myers AM; Harrison GS
    Biol Blood Marrow Transplant; 1999; 5(3):162-72. PubMed ID: 10392962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection.
    Cu-Uvin S; Ko H; Jamieson DJ; Hogan JW; Schuman P; Anderson J; Klein RS;
    Clin Infect Dis; 2002 May; 34(10):1406-11. PubMed ID: 11981738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Falke D; Kabelitz D; Friese K; Helm EB; Hoelzer D; Rossol-Voth R
    Eur J Med Res; 1996 Feb; 1(5):249-58. PubMed ID: 9374446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man.
    Martin-Rico P; Pedersen C; Skinhøj P; Nielsen C; Lindhardt BO
    AIDS; 1995 Jan; 9(1):95-6. PubMed ID: 7893450
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection.
    Bahr GM; Capron A; Dewulf J; Nagata S; Tanaka M; Bourez JM; Mouton Y
    Blood; 1997 Jul; 90(2):896-8. PubMed ID: 9226197
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function.
    Wang Zq; Horowitz HW; Orlikowsky T; Hahn BI; Trejo V; Bapat AS; Mittler RS; Rayanade RJ; Yang SY; Hoffmann MK
    J Infect Dis; 1999 Oct; 180(4):1072-9. PubMed ID: 10479133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic correlates of protection against HIV infection: the ally within.
    Piacentini L; Biasin M; Fenizia C; Clerici M
    J Intern Med; 2009 Jan; 265(1):110-24. PubMed ID: 19093964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte precursors in persons with repeated exposure to human immunodeficiency virus.
    Forthal DN
    J Infect Dis; 1999 Oct; 180(4):1406-7. PubMed ID: 10479184
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers in HIV infection.
    Lange JM; Goudsmit J; De Wolf F; Coutinho RA; van der Noordaa J
    Ann Med Interne (Paris); 1988; 139(2):80-3. PubMed ID: 3293504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Murex HIV Ag/Ab Combination assay when used with dried blood spots.
    Lakshmi V; Sudha T; Bhanurekha M; Dandona L
    Clin Microbiol Infect; 2007 Nov; 13(11):1134-6. PubMed ID: 17725648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is the patient's HIV status?].
    Christiansen CB
    Ugeskr Laeger; 2000 May; 162(20):2912. PubMed ID: 10860440
    [No Abstract]   [Full Text] [Related]  

  • 19. The T cell receptor V beta repertoire in HIV-1 infection and disease.
    Soudeyns H; Rebai N; Pantaleo GP; Ciurli C; Boghossian T; Sékaly RP; Fauci AS
    Semin Immunol; 1993 Jun; 5(3):175-85. PubMed ID: 8102262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Central nervous system lesions in the early stages of HIV infection].
    Wingertsmann L; Chrétien F; Authier FJ; Paraire F; Durigon M; Gray F
    Arch Anat Cytol Pathol; 1997; 45(2-3):106-17. PubMed ID: 9382601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.